Assertio Therapeutics
ASRT
#9487
Rank
S$99.62 M
Marketcap
S$15.53
Share price
5.44%
Change (1 day)
1,251.77%
Change (1 year)

Earnings for Assertio Therapeutics (ASRT)

Earnings in 2025 (TTM): -S$35.06 Million

According to Assertio Therapeutics 's latest financial reports the company's current earnings are S$0.13 Billion. In 2024 the company made an earning of -S$24.29 Million, an increase over its 2023 earnings that were of -S$0.33 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Assertio Therapeutics from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$35.06 Million44.33%
2024 -S$24.29 Million-92.46%
2023 -S$0.33 Billion-744.93%
2022 S$49.95 M304.52%
2021 S$12.35 M-132.53%
2020 -S$37.97 Million-81.97%
2019 -S$0.22 Billion-253.57%
2018 S$0.13 B-451.81%
2017 -S$38.97 Million-258.05%
2016 S$24.65 M-138.59%
2015 -S$63.9 Million-121.01%
2014 S$0.30 B2275.01%
2013 S$12.8 M-133.45%
2012 -S$38.28 Million-141.87%
2011 S$91.41 M1496.17%
2010 S$5.72 M-121.23%
2009 -S$26.98 Million22.98%
2008 -S$21.94 Million-135.96%
2007 S$60.99 M
2003 -S$37.72 Million
2000 -S$9.93 Million43.5%
1999 -S$6.92 Million58.6%
1998 -S$4.37 Million580%
1997 -S$0.65 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-S$23.3 Million-31.08%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-S$0.21 Billion 505.39%๐Ÿ‡บ๐Ÿ‡ธ USA